Why is Bliss GVS Pharma falling/rising?

As of 03-Jul, Bliss GVS Pharma Ltd's stock price is currently at 156.50, reflecting an increase of 1.55 (1.0%). The stock has shown a positive performance today, outperforming its sector by 0.52% and achieving a consecutive gain over the last two days with a total return of 1.39%. Additionally, the stock has touched an intraday high of Rs 160.85, indicating strong upward momentum. Over the past week, Bliss GVS Pharma has returned +5.03%, significantly outperforming the Sensex, which has declined by -0.62%. However, despite a robust one-year return of 51.35%, the company has faced challenges, including a -19.5% decline in profits over the same period and negative results for the last three consecutive quarters, which may raise concerns among investors.
In the broader market context, while Bliss GVS Pharma has demonstrated strong short-term performance, its year-to-date return of -4.95% contrasts with the Sensex's gain of +6.53%. This divergence suggests that despite recent positive movements, the stock may be struggling to maintain investor confidence in the long term due to poor growth metrics, such as a -2.54% annual decline in operating profit over the past five years. Furthermore, the lack of domestic mutual fund investment, which stands at 0%, may indicate a cautious sentiment towards the stock's valuation and business prospects, potentially influencing its price movements in the market.